Trial in Progress: Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated with Systemic Therapy from Real-World Experience (ORCHID)

被引：0
|
作者：
Thieblemont, Catherine [1 ]
Ma, Qiufei [2 ]
Hampp, Christian [2 ]
Harnett, James [2 ]
Sober, Rachel E. [2 ]
Jalbert, Jessica J. [2 ]
Quek, Ruben G. W. [2 ]
Wei, Wenhui [2 ]
Wu, Ning [2 ]
Mastey, Vera [2 ]
Wang, Joy [2 ]
Bajwa, Anit [2 ]
Maissenhaelter, Benedikt [3 ]
van Gils, Chantal [4 ]
Aggarwal, Shivani [5 ]
Chaudhry, Aafia [2 ]
Mohamed, Hesham [2 ]
Ambati, Srikanth R. [2 ]
Bachy, Emmanuel [6 ,7 ]
Damaj, Gandhi Laurent [8 ]
机构：
[1] Univ Paris, Hop St Louis, AP HP, Hematooncol, Paris, France
[2] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
[3] IQVIA, Munich, Germany
[4] IQVIA, Rotterdam, Netherlands
[5] IQVIA, Los Angeles, CA USA
[6] Hosp Civils Lyon, Lyon, France
[7] Univ Claude Bernard Lyon 1, Lyon, France
[8] Univ Normandie, Inst Hematol Basse Normandie, CHU Cote Nacre, Caen, France
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-158418
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8065 / 8067
页数：3
相关论文
共 50 条
  • [1] Outcomes in patients (pts) with relapsed/refractory (R/R) diffuse large B cell lymphoma (DLBCL) treated with systemic therapy from real world experience (ORCHID) study.
    Damaj, Gandhi Laurent
    Hampp, Christian
    Bachy, Emmanuel
    Prochazka, Katharina
    Jo, Jae-Cheol
    Kim, Tae Min
    Oberic, Lucie
    Townsend, William
    Jalbert, Jessica J.
    Ma, Qiufei
    Kamat, Siddhesh
    Wang, Joy
    Ambati, Srikanth R.
    Mohamed, Hesham
    Chaudhry, Aafia
    Thorley, Eileen
    Rippin, Gerd
    Harnett, James
    Thieblemont, Catherine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy
    Argnani, Lisa
    Broccoli, Alessandro
    Pellegrini, Cinzia
    Fabbri, Alberto
    Puccini, Benedetta
    Bruna, Riccardo
    Tisi, Maria Chiara
    Masia, Francesco
    Flenghi, Leonardo
    Nizzoli, Maria Elena
    Musso, Maurizio
    Salerno, Marilena
    Scalzulli, Potito Rosario
    Dessi', Daniela
    Ferrarini, Isacco
    Pennese, Elsa
    Lucchini, Elisa
    Rossi, Francesca Gaia
    Minoia, Carla
    Gherlinzoni, Filippo
    Musto, Pellegrino
    Patti, Caterina
    Stefoni, Vittorio
    Zinzani, Pier Luigi
    [J]. HEMASPHERE, 2022, 6 (12): : E798
  • [3] Real-world outcomes with novel therapies in relapsed/refractory diffuse large B-cell lymphoma
    Crombie, Jennifer L.
    Jun, Monika
    Wang, Tongsheng
    Mutebi, Alex
    Wang, Anthony
    Chhibber, Anindit
    Kamalakar, Rajesh
    Ukropec, Jon
    Blaedel, Julie
    Kalsekar, Anupama
    [J]. LEUKEMIA & LYMPHOMA, 2024,
  • [4] Trial in Progress: Follicular Lymphoma Outcomes in Relapsed/Refractory Patients Treated with Systemic Therapy in a Real-World Assessment (FLORA)
    Bachy, Emmanuel
    Damaj, Gandhi Laurent
    Ma, Qiufei
    Hampp, Christian
    Harnett, James
    Sobel, Rachel E.
    Jalbert, Jessica J.
    Quek, Ruben G. W.
    Wei, Wenhui
    Wu, Ning
    Mastey, Vera
    Wang, Joy
    Bajwa, Anit
    Maissenhaelter, Benedikt
    van Gils, Chantal
    Aggarwal, Shivani
    Chaudhry, Aafia
    Mohamed, Hesham
    Ambati, Srikanth R.
    Thieblemont, Catherine
    [J]. BLOOD, 2022, 140 : 5198 - 5200
  • [5] Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma
    Chihara, Dai
    Liao, Laura
    Tkacz, Joseph
    Franco, Anjali
    Lewing, Benjamin
    Kilgore, Karl M.
    Nastoupil, Loretta J.
    Chen, Lei
    [J]. BLOOD, 2023, 142 (12) : 1047 - 1055
  • [6] Real-world practice patterns and outcomes in Veterans with relapsed/refractory diffuse large B-cell lymphoma
    Chien, Hsu-Chih
    Morreall, Deborah
    Patil, Vikas
    Rasmussen, Kelli M.
    Li, Chungyang
    Yong, Christina M.
    Burningham, Zachary
    Masaquel, Anthony
    Halloran, Mary
    De Long-Sieg, Elisha
    Schulz, Mathias
    Sauer, Brian C.
    Halwani, Ahmad S.
    [J]. FUTURE ONCOLOGY, 2020, 17 (04) : 411 - 422
  • [7] Real-World Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Standard of Care: A Cota Database Analysis
    Ip, Andrew
    Mutebi, Alex
    Wang, Tongsheng
    Jun, Monika P.
    Kalsekar, Anupama
    Navarro, Fernando Rivas
    Wang, Anthony
    Kamalakar, Rajesh
    Sacchi, Mariana
    Elliott, Brian
    [J]. BLOOD, 2022, 140 : 6693 - 6694
  • [8] Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data
    Atesoglu, Elif Birtas
    Gulbas, Zafer
    Uzay, Ant
    Ozcan, Muhit
    Ozkalemkas, Fahir
    Dal, Mehmet Sinan
    Kalyon, Hakan
    Akay, Olga Meltem
    Deveci, Burak
    Bekoz, Huseyin
    Sevindik, Omur Gokmen
    Toptas, Tayfur
    Yilmaz, Fergun
    Koyun, Derya
    Alkis, Nihan
    Alacacioglu, Inci
    Sonmez, Mehmet
    Yavasoglu, Irfan
    Tombak, Anil
    Mehtap, Ozgur
    Kurnaz, Fatih
    Yuce, Orhan Kemal
    Karakus, Volkan
    Turgut, Mehmet
    Kurekci, Derya Deniz
    Ayer, Mesut
    Keklik, Muzaffer
    Buyuktas, Deram
    Ozbalak, Murat
    Ferhanoglu, Burhan
    [J]. HEMATOLOGICAL ONCOLOGY, 2023, 41 (04) : 663 - 673
  • [9] Challenges in Administering Salvage Therapy and Outcomes of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: A LMIC Real-World Study
    Charanpreet Singh
    Aditya Jandial
    Arihant Jain
    Deepesh Lad
    Alka Khadwal
    Rajender Basher
    Amanjit Bal
    Pankaj Malhotra
    Gaurav Prakash
    [J]. Indian Journal of Hematology and Blood Transfusion, 2024, 40 : 231 - 236
  • [10] Challenges in Administering Salvage Therapy and Outcomes of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: A LMIC Real-World Study
    Singh, Charanpreet
    Jandial, Aditya
    Jain, Arihant
    Lad, Deepesh
    Khadwal, Alka
    Basher, Rajender
    Bal, Amanjit
    Malhotra, Pankaj
    Prakash, Gaurav
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (02) : 231 - 236
12345